GINWA(600080)
Search documents
金花股份:2025年净利润预同比减少81.24%到73.19%
Zheng Quan Ri Bao Zhi Sheng· 2026-01-23 14:20
(编辑 丛可心) 证券日报网讯 1月23日,金花股份发布公告称,公司预计2025年度实现归属于母公司所有者的净利润为 1,400.00万元到2,000.00万元,与上年同期7,461.13万元相比,将减少6,061.13万元到5,461.13万 元,同比减少81.24%到73.19%。 ...
金花股份(600080.SH):预计2025年度净利润同比减少81.24%到73.19%
Ge Long Hui A P P· 2026-01-23 10:04
格隆汇1月23日丨金花股份(维权)(600080.SH)公布,经公司财务部门初步测算,预计公司2025年度实 现归属于母公司所有者的净利润为1,400.00万元到2,000.00万元,同比减少81.24%到73.19%。预计公司 2025年度实现归属于母公司所有者的扣除非经常性损益后的净利润为1,200.00万元到1,700.00万元,与上 年同期(法定披露数据)相比,将变动-177.49万元到322.51万元,同比变动-12.89%到23.41%。 本报告期,公司实现归属于母公司所有者的净利润较上年减少,主要系上年同期处置全资子公司金花国 际大酒店有限公司100%股权,确认投资收益3,432.99万元,同时公司取得金花国际大酒店有限公司股权 初始成本与处置时该股权账面价值之间的差额相应增加了公司税前可抵扣应纳税所得额,导致减少上年 所得税费用3,900.23万元。 ...
金花股份:预计2025年度净利润同比减少81.24%到73.19%
Ge Long Hui· 2026-01-23 10:02
格隆汇1月23日丨金花股份(600080.SH)公布,经公司财务部门初步测算,预计公司2025年度实现归属于 母公司所有者的净利润为1,400.00万元到2,000.00万元,同比减少81.24%到73.19%。预计公司2025年度 实现归属于母公司所有者的扣除非经常性损益后的净利润为1,200.00万元到1,700.00万元,与上年同期 (法定披露数据)相比,将变动-177.49万元到322.51万元,同比变动-12.89%到23.41%。 本报告期,公司实现归属于母公司所有者的净利润较上年减少,主要系上年同期处置全资子公司金花国 际大酒店有限公司100%股权,确认投资收益3,432.99万元,同时公司取得金花国际大酒店有限公司股权 初始成本与处置时该股权账面价值之间的差额相应增加了公司税前可抵扣应纳税所得额,导致减少上年 所得税费用3,900.23万元。 ...
金花股份(600080) - 2025 Q4 - 年度业绩预告
2026-01-23 09:50
证券代码:600080 股票简称:金花股份 编号:临 2026-004 金花企业(集团)股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 本次业绩预告适用于实现盈利,且净利润与上年同期相比下降 50%以上 的情形。 报告期内,金花企业(集团)股份有限公司(以下简称"公司")预 计 2025 年度实现归属于母公司所有者的净利润为 1,400.00 万元到 2,000.00 万 元;预计 2025 年实现归属于母公司所有者的扣除非经常性损益后的净利润为 1,200.00 万元到 1,700.00 万元。 二、上年同期经营业绩和财务状况 (一)利润总额:4,203.93 万元。归属于母公司所有者的净利润:7,461.13 万元。归属于母公司所有者的扣除非经常性损益的净利润:1,377.49 万元。 (二)每股收益:0.2088 元。 一、本期业绩预告情况 (一)业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 (二)业绩预告情况 1、经公司财 ...
金花股份涨2.08%,成交额2197.16万元,主力资金净流入17.88万元
Xin Lang Cai Jing· 2026-01-19 03:00
Group 1 - The core viewpoint of the news is that Jinhua Co., Ltd. has shown fluctuations in its stock price and financial performance, with a recent increase in stock price and mixed performance in revenue and profit [1][2]. Group 2 - As of January 19, Jinhua's stock price increased by 2.08% to 7.86 CNY per share, with a total market capitalization of 2.934 billion CNY [1]. - Year-to-date, Jinhua's stock price has risen by 4.24%, but it has experienced a decline of 1.26% over the last five trading days and 1.38% over the last twenty days [2]. - The company reported a revenue of 384 million CNY for the first nine months of 2025, a year-on-year decrease of 8.36%, while the net profit attributable to shareholders was 34.4812 million CNY, an increase of 12.06% [2]. Group 3 - Jinhua Co., Ltd. has a primary business focus on the research, production, and sales of pharmaceuticals, with 99.71% of its revenue coming from drug sales [2]. - The company has distributed a total of 118 million CNY in dividends since its A-share listing, with 10.5814 million CNY distributed over the past three years [3].
中药板块1月8日涨0.31%,沃华医药领涨,主力资金净流出4.93亿元
Zheng Xing Xing Ye Ri Bao· 2026-01-08 08:51
Market Overview - The Traditional Chinese Medicine (TCM) sector saw a slight increase of 0.31% on January 8, with WoHua Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Top Performers - WoHua Pharmaceutical (002107) closed at 7.13, up 5.63% with a trading volume of 298,400 shares and a turnover of 210 million yuan [1] - Enwei Pharmaceutical (301331) closed at 29.06, up 5.52% with a trading volume of 29,600 shares and a turnover of 85 million yuan [1] - Jinhua Co., Ltd. (600080) closed at 8.03, up 4.69% with a trading volume of 137,600 shares and a turnover of 110 million yuan [1] Underperformers - Jilin Aodong (000623) closed at 20.04, down 2.48% with a trading volume of 206,000 shares and a turnover of 416 million yuan [2] - Panlong Pharmaceutical (002864) closed at 34.32, down 1.58% with a trading volume of 149,000 shares and a turnover of 524 million yuan [2] - RY Pharmaceutical (600332) closed at 25.04, down 1.57% with a trading volume of 486,000 shares and a turnover of 122 million yuan [2] Capital Flow - The TCM sector experienced a net outflow of 493 million yuan from institutional investors, while retail investors saw a net inflow of 378 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are actively buying [2] Individual Stock Capital Flow - Huaren Sanjiu (6660000) had a net inflow of 57.91 million yuan from institutional investors, while it faced a net outflow of 51.38 million yuan from speculative funds [3] - Yunnan Baiyao (000538) saw a net inflow of 42.56 million yuan from institutional investors, but also experienced outflows from both speculative and retail investors [3] - Wanbangde (002082) had a net inflow of 26.36 million yuan from institutional investors, with outflows from speculative and retail investors [3]
金花企业(集团)股份有限公司关于集中竞价减持已回购股份的进展公告
Shang Hai Zheng Quan Bao· 2026-01-06 17:42
Core Viewpoint - The company, Jinhua Enterprises (Group) Co., Ltd., has announced the progress of its share repurchase and reduction plan, indicating that it has not yet executed the planned reduction of repurchased shares as of the end of December 2025 [2][3]. Group 1: Share Repurchase Details - The company repurchased a total of 20,557,582 shares from February 23, 2024, to May 22, 2024, which accounts for 5.51% of its total share capital [2]. - Out of the repurchased shares, 2,750,000 shares (0.74% of total share capital) were allocated for employee stock ownership plans or equity incentives, while 17,807,582 shares (4.77% of total share capital) were repurchased to maintain company value and protect shareholder interests [2]. Group 2: Reduction Plan Progress - The company disclosed a plan on October 30, 2025, to reduce up to 7,465,405 repurchased shares (2% of total share capital) through centralized bidding within six months following the announcement [3]. - As of November 30, 2025, the company had not yet executed any reductions of the repurchased shares, and this status remained unchanged as of December 31, 2025 [3][3]. Group 3: Compliance and Regulations - The company is required to disclose the progress of the share reduction plan within the first three trading days of each month, based on the previous month's status [5]. - The reduction plan is consistent with prior commitments made by major shareholders and does not involve any significant corporate actions such as high stock dividends or mergers during the reduction period [6][7].
金花股份(600080) - 金花企业(集团)股份有限公司关于集中竞价减持已回购股份的进展公告
2026-01-06 08:16
证券代码:600080 证券简称:金花股份 公告编号:2026-003 金花企业(集团)股份有限公司 关于集中竞价减持已回购股份的进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 回购股份的基本情况 金花企业(集团)股份有限公司(以下简称"公司")于 2024 年 2 月 23 日 至 2024 年 5 月 22 日期间通过集中竞价交易方式累计回购公司股份 20,557,582 股,占公司总股本的 5.51%。其中,用于员工持股计划或股权激励累计回购股份 2,750,000 股(占公司总股本 0.74%);用于维护公司价值及股东权益累计回购股 份 17,807,582 股(占公司总股本 4.77%)。具体内容详见公司于 2024 年 5 月 22 日披露的《关于股份回购实施结果暨股份变动的公告》(公告编号:2024-037 号)。 减持计划的进展情况 2025 年 10 月 30 日,公司披露了《金花企业(集团)股份有限公司关于回 购股份集中竞价减持计划的公告》(公告编号:2025-044 号 ...
金花股份(600080) - 金花企业(集团)股份有限公司关于控股股东部分股份质押的公告
2026-01-05 08:00
关于控股股东部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码:600080 股票简称:金花股份 编号:临 2026-002 金花企业(集团)股份有限公司 (二)本次股份质押不存在被用作重大资产重组业绩补偿等事项的担保或其 他保障用途。 (三)股东累计质押股份情况 上表中质押起始日为质押合同签订日,质押到期日具体以实际解除质押登记 日期为准。 | | 持股数量 | 持股 | 本次质押前 | 本次质押后 | 占其所 | 占公司 | 已质押股份情况 已质押股 | 已质押股 | 未质押股份情况 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 名称 | (股) | 比例 | 累计质押数 | 累计质押数 | 持股份 | 总股本 | | | | 未质押股 | | | | | 量(股) | 量(股) | 比例 | 比例 | 份中限售 | 份中冻结 | 中限售股份 | 份中冻结 | | | | ...
金花股份:控股股东邢博越质押580万股股份用于企业经营
Xin Lang Cai Jing· 2026-01-05 07:47
Core Viewpoint - The controlling shareholder and actual controller of Jinhua Co., Xing Boyue, has pledged 5.8 million shares, which is 6.12% of his holdings and 1.55% of the total share capital, to Wuhan Zhiyi Trading for business operations [1] Group 1 - Xing Boyue holds a total of 94.7924 million shares, representing 25.40% of the total share capital [1] - After the recent pledge, the cumulative pledged shares amount to 73.97 million, which is 78.03% of his holdings and 19.82% of the total share capital [1] - The financing balance corresponding to the pledged shares due in the next six months and one year is 23 million yuan and 250 million yuan, respectively, indicating that the pledge risk is controllable [1]